Pulmonary Medicine in Keio→NIID→UNC at Chapel Hill→Saitama→Kitasato→Keio Assisitant Professor. Bronchiectasis and NTM lung disease focusing epitheliall cells.
Tokyo, Japan
Joined September 2021
- Tweets348
- Following155
- Followers310
- Likes852
Pinned Tweet
I am thrilled to share my non-cystic fibrosis bronchiectasis (NCFB) work collaborating with Japan and the US @UNC online in @ATSBlueEditor. We evaluated the bronchiolar manifestation of NCFB, focusing on region-specific markers and mucociliary clearance. atsjournals.org/doi/abs/10.1…
It was a great pleasure to attend KATRDIC 2026 in Seoul last week! Many thanks to my dear friend Dr. Hayoung Choi @hayoungcc for the kind invitation. I truly enjoyed the inspiring discussions, warm hospitality, and great time with friends and colleagues in Korea!
#KATRDIC2026
Takanori Asakura, MD, PhD retweeted
So great to welcome my friend @MEDAsakura to #KATRDIC and hear his wonderful talk on mucociliary clearance in #bronchiectasis!
New publication! We report pulmonary disease caused by a previously unclassified NTM after cord blood transplantation. Genomic analyses led us to propose the name Mycobacterium meguroense. Multidrug therapy was followed by culture conversion.
doi.org/10.1016/j.nmni.2026.…
#NTM #NTMPD
Delighted to share our editorial in @ERSpublications—thanks to @hayoungcc for taking the lead!
Nasal nitric oxide should open the door to PCD diagnosis—not close it.
Let’s raise awareness of PCD in adults with bronchiectasis.
publications.ersnet.org/cont…
#PCDAwarenessMonth #PCD
Takanori Asakura, MD, PhD retweeted
Perfect timing for #PCDAwarenessMonth 🫁 Delighted to share our ERJ @ERSpublications editorial with the brilliant @MEDAsakura!
Nasal nitric oxide as a gateway, not a gatekeeper, to primary ciliary dyskinesia diagnosis in bronchiectasis publications.ersnet.org/cont…
Takanori Asakura, MD, PhD retweeted
A nearly 70% reduction in exacerbations for bronchiectasis patients in Japan treated with Brensocatib
Consist with other trials I’ve led showing enhanced response in people from Asia
Mechanism unknown. Studies ongoing to find out!
sciencedirect.com/science/ar…
Takanori Asakura, MD, PhD retweeted
New subgroup analysis from the #ASPEN trial shows that brensocatib significantly reduced pulmonary exacerbations by ~60% in participants of Asian race with #bronchiectasis.
pubmed.ncbi.nlm.nih.gov/4246…
Our article on the association between corticosteroid therapy and Long COVID symptoms was highlighted in Drug Topics and featured in the @atscommunity newsletter.
resmedjournal.com/article/S0…
drugtopics.com/view/study-li…
The NTM-JRC YouTube channel now has all our past public seminars on NTM and bronchiectasis. Videos are in Japanese, with subtitles available in other languages. I often share them with patients at diagnosis and hope they help others. youtube.com/@npo_ntm-jrc6590
I had the opportunity to present at the WBC 2026 in Hannover last week. It was a wonderful experience in a beautiful city, with warm people and many inspiring conversations. I hope to keep contributing to this field and to advancing bronchiectasis care and research in Japan.
Takanori Asakura, MD, PhD retweeted
Mucus plugs and why do they matter?
Are they a consequence of, or a cause for, bronchiectasis?
Different types of mucus plug make up shown to be different across asthma severity.
#mucusmatters
Takanori Asakura, MD, PhD retweeted
BREAKING🔔 The 57th paper from G2P-Japan🇯🇵 is out at Cell @CellPressNews🦇!! We elucidated the virological characteristics of a new bat coronavirus identified in Thailand🇹🇭
The debut work by “G2P-Asia🌏”. Please repost🔥
cell.com/cell/fulltext/S0092…
Mini reunion at the Japanese Respiratory Society Annual Meeting this weekend with former postdocs from Duke and UNC!
@yoshi_koba_jp @KonishiSatoshi
Takanori Asakura, MD, PhD retweeted
Wonderful day at the Japanese Respiratory Society annual meeting, talking about new concepts in #bronchiectasis management. Also, pleased to catch up with my friend @MEDAsakura and meet new colleagues!
I bought a physical book for the first time in a while. The texture feels great, and it already seems like such a rewarding read.
Delighted to share our publication in IJID: Predicting Progression of MAC-PD with Treatment Using Explainable Artificial Intelligence Techniques. Our explainable AI model may help predict progression for treatment.
ijidonline.com/article/S1201…
@ISID_org
Delighted to share our publication in EID: “M. riyadhense Pulmonary Disease after Relocation from Saudi Arabia, Japan.” This case might represent within-host persistence of a preexisting infection rather than newly acquired infection in Japan.
@CDC_NCEZID wwwnc.cdc.gov/eid/article/32…
Takanori Asakura, MD, PhD retweeted
9th World Bronchiectasis Conference 2026, Hannover.
14 sessions over 4 days with global experts, early-career activities, posters & more.
Session 1 (Pathophysiology) kicks things - 24 June
👉 Register now: world-bronchiectasis-confere…
#WBConf26
Prognosis of patients with bronchiectasis receiving long-term oxygen therapy
sciencedirect.com/science/ar…
Thrilled to share our study comparing supine vs upright CT in bronchiectasis and NTM-PD: quantitative airway metrics, associations with PFTs, bronchiectatic regions, and alveolar involvement in mild BE subjects consistent with our prior AJRCCM work.
ejradiology.com/article/S072…
Just published the final version as follows!
ejradiology.com/article/S072…
